Impact of the COVID-19 pandemic on opioid overdose and other adverse events in the USA and Canada: a systematic review.
Regional Anesthesia and Pain Medicine · 2022-10-06 · Systematic review
Abstract
IMPORTANCE: The COVID-19 pandemic impacted healthcare beyond COVID-19 infections. A better understanding of how COVID-19 worsened the opioid crisis has potential to inform future response efforts. OBJECTIVE: To summarize changes from the COVID-19 pandemic on outcomes regarding opioid use and misuse in the USA and Canada. EVIDENCE REVIEW: We searched MEDLINE via PubMed, EMBASE, and CENTRAL for peer-reviewed articles published between March 2020 and December 2021 that examined outcomes relevant to patients with opioid use, misuse, and opioid use disorder by comparing the period before vs after COVID-19 onset in the USA and Canada. Two reviewers independently screened studies, extracted data, assessed methodological quality and bias via Newcastle-Ottawa Scale, and synthesized results. FINDINGS: Among 20 included studies, 13 (65%) analyzed service utilization, 6 (30%) analyzed urine drug testing results, and 2 (10%) analyzed naloxone dispensation. Opioid-related emergency medicine utilization increased in most studies (85%, 11/13) for both service calls (17% to 61%) and emergency department visits (42% to 122%). Urine drug testing positivity results increased in all studies (100%, 6/6) for fentanyl (34% to 138%), most (80%, 4/5) studies for heroin (-12% to 62%), and most (75%, 3/4) studies for oxycodone (0% to 44%). Naloxone dispensation was unchanged and decreased in one study each. INTERPRETATION: Significant increases in surrogate measures of the opioid crisis coincided with the onset of COVID-19. These findings serve as a call to action to redouble prevention, treatment, and harm reduction efforts for the opioid crisis as the pandemic evolves. PROSPERO REGISTRATION NUMBER: CRD42021236464.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Analgesics · Antidotes · COVID-19 pandemic · Fentanyl · Heroin · Naloxone · Oxycodone · Poisoning & substance use
Related articles
- Opioid Epidemic Through the Lens of Prehospital Emergency Care: A 5-Year Descriptive Analysis of the Statewide Opioid Response Directive (SWORD) Surveillance Program. (Prehosp Emerg Care, 2025)
- Naloxone-associated pulmonary edema following recreational opioid overdose. (Am J Emerg Med, 2022)
- Spatial and neighborhood-level correlates of lay naloxone reversal events and service availability. (Int J Drug Policy, 2022)
- Emergency Department-Administered Extended-Release Buprenorphine After Fentanyl Overdose Reversed by Emergency Medical Services With Naloxone. (J Emerg Med, 2026)
- Outcomes of law enforcement officer administered naloxone. (Am J Emerg Med, 2022)
- Pitfalls of intranasal naloxone. (Prehosp Emerg Care, 2014)